What would make getting colorectal cancer screening easier? Perspectives from screeners and nonscreeners

Gilda G Medina, Amy McQueen, Anthony J Greisinger, L Kay Bartholomew, Sally W Vernon, Gilda G Medina, Amy McQueen, Anthony J Greisinger, L Kay Bartholomew, Sally W Vernon

Abstract

Background. Despite the availability of multiple effective tests for colorectal cancer (CRC), screening rates are low. Greater understanding of barriers between screeners and nonscreeners may improve public health initiatives to increase CRC screening (CRCS). Methods. We conducted a content analysis of 625 responses to the question: "Was there anything that would have made getting tested easier?" Respondents were patients at a multispecialty practice who participated in a behavioral intervention trial to increase CRCS. Using clinic records, we classified patients as early-screeners (<6 months), late-screeners(6-12 months), and nonscreeners (>12 months). Results. Both screeners and nonscreeners reported the same categories of barriers. However, early-screeners predominantly cited dislike of test attributes such as bowel preparation, whereas nonscreeners cited concerns regarding finances and work and family responsibilities. Conclusion. Multilevel strategies that address scheduling barriers and external screening barriers may improve CRCS. Future studies may test hypotheses about mediators explaining how screeners overcome barriers.

References

    1. American Cancer Society. Cancer Facts & Figures. 2010.
    1. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine. 2008;149(9):627–637.
    1. Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiology Biomarkers and Prevention. 2006;15(2):389–394.
    1. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer. 2003;97(6):1528–1540.
    1. Shapiro JA, Seeff LC, Thompson TD, Nadel MR, Klabunde CN, Vernon SW. Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiology Biomarkers and Prevention. 2008;17(7):1623–1630.
    1. Klabunde CN, Vernon SW, Nadel MR, Breen N, Seeff LC, Brown ML. Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults. Medical Care. 2005;43(9):939–944.
    1. Finney Rutten LJ, Nelson DE, Meissner HI. Examination of population-wide trends in barriers to cancer screening from a diffusion of innovation perspective (1987–2000) Preventive Medicine. 2004;38(3):258–268.
    1. McQueen A, Vernon SW, Meissner HI, Klabunde CN, Rakowski W. Are there gender differences in colorectal cancer test use prevalence and correlates? Cancer Epidemiology Biomarkers and Prevention. 2006;15(4):782–791.
    1. Seeff LC, Nadel MR, Klabunde CN, et al. Patterns and predictors of colorectal cancer test use in the adult U.S. population: results from the 2000 National Health Interview Survey. Cancer. 2004;100(10):2093–2103.
    1. Wee CC, McCarthy EP, Phillips RS. Factors associated with colon cancer screening: the role of patient factors and physician counseling. Preventive Medicine. 2005;41(1):23–29.
    1. Tessaro I, Mangone C, Parkar I, Pawar V. Knowledge, barriers, and predictors of colorectal cancer screening in an Appalachian church population. Preventing Chronic Disease. 2006;3(4):p. A123.
    1. Denberg TD, Melhado TV, Coombes JM, et al. Predictors of nonadherence to screening colonoscopy. Journal of General Internal Medicine. 2005;20(11):989–995.
    1. Jones RM, Woolf SH, Cunningham TD, et al. The relative importance of patient-reported barriers to colorectal cancer screening. American Journal of Preventive Medicine. 2010;38(5):499–507.
    1. Ogedegbe G, Cassells AN, Robinson CM, et al. Perceptions of barriers and facilitators of cancer early detection among low-income minority women in community health centers. Journal of the National Medical Association. 2005;97(2):162–170.
    1. Harewood GC, Wiersema MJ, Melton LJ. A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy. American Journal of Gastroenterology. 2002;97(12):3186–3194.
    1. Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Ca-A Cancer Journal for Clinicians. 2001;51(1):38–75.
    1. Vernon SW, Bartholomew LK, McQueen A, et al. A randomized controlled trial of a tailored interactive computer-delivered intervention to promote colorectal cancer screening: sometimes more is just the same. Annals of Behavioral Medicine. 2011;41(3):284–299.
    1. Lofland JF, Lofland LH. Analyzing Social Settings: A Guide to Qualitative Observation and Analysis. Wadsworth; 1995.
    1. McQueen A, Bartholomew LK, Greisinger AJ, et al. Behind closed doors: physician-patient discussions about colorectal cancer screening. Journal of General Internal Medicine. 2009;24(11):1228–1235.
    1. Ko CW, Riffle S, Shapiro JA, et al. Incidence of minor complications and time lost from normal activities after screening or surveillance colonoscopy. Gastrointestinal Endoscopy. 2007;65(4):648–656.
    1. Stone EG, Morton SC, Hulscher ME, et al. Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Annals of Internal Medicine. 2002;136(9):641–651.
    1. Potter MB, Phengrasamy L, Hudes ES, McPhee SJ, Walsh JME. Offering annual fecal occult blood tests at annual flu shot clinics increases colorectal cancer screening rates. Annals of Family Medicine. 2009;7(1):17–23.
    1. Rim SH, Joseph DA, Steele CB, Thompson TD, Seeff LC. Colorectal cancer screening—United States, 2002, 2004, 2006, and 2008. MMWR Surveillance Summaries. 2011;60:42–46.
    1. Hawley ST, McQueen A, Bartholomew LK, et al. Preferences for colorectal cancer screening tests and screening test use in a large multi-specialty primary care practice. Cancer. In press.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren